| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.
|
JAMA
|
2000
|
6.37
|
|
2
|
Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.
|
J Natl Cancer Inst
|
2000
|
4.89
|
|
3
|
Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.
|
J Natl Cancer Inst
|
2001
|
3.00
|
|
4
|
Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study.
|
J Natl Cancer Inst
|
1999
|
2.59
|
|
5
|
Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study.
|
J Natl Cancer Inst
|
2001
|
2.09
|
|
6
|
Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study.
|
J Clin Oncol
|
2001
|
1.86
|
|
7
|
Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer.
|
J Urol
|
1996
|
1.66
|
|
8
|
Fibrin glue for partial nephrectomy.
|
Urology
|
1991
|
1.59
|
|
9
|
Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study.
|
J Urol
|
1999
|
1.56
|
|
10
|
Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study.
|
J Clin Oncol
|
2001
|
1.46
|
|
11
|
Role of transurethral resection of the prostate in population-based prostate cancer incidence rates.
|
Am J Epidemiol
|
1999
|
1.27
|
|
12
|
Heritability of prostate-specific antigen and relationship with zonal prostate volumes in aging twins.
|
J Clin Endocrinol Metab
|
2000
|
0.99
|
|
13
|
Diterpenoid sweeteners. Synthesis and sensory evaluation of stevioside analogues with improved organoleptic properties.
|
J Med Chem
|
1985
|
0.99
|
|
14
|
Cellular proliferative fraction of metastatic lymph nodes predicts survival in stage D1 (TxN+M0) prostate cancer.
|
J Urol
|
1996
|
0.98
|
|
15
|
Age, genetic, and nongenetic factors influencing variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twins.
|
Prostate
|
1997
|
0.96
|
|
16
|
Allelic loss detected on chromosomes 8, 10, and 17 by fluorescence in situ hybridization using single-copy P1 probes on isolated nuclei from paraffin-embedded prostate tumors.
|
Am J Pathol
|
1997
|
0.92
|
|
17
|
Trends in mortality rates in patients with prostate cancer during the era of prostate specific antigen screening.
|
J Urol
|
2000
|
0.91
|
|
18
|
High energy shock waves suppress tumor growth in vitro and in vivo.
|
J Urol
|
1986
|
0.91
|
|
19
|
Effect of section thickness on quality of flow cytometric DNA content determinations in paraffin-embedded tissues.
|
Cytometry
|
1986
|
0.90
|
|
20
|
Commonly occurring loss and mutation of the MXI1 gene in prostate cancer.
|
Genes Chromosomes Cancer
|
1998
|
0.89
|
|
21
|
Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system.
|
Urology
|
1997
|
0.87
|
|
22
|
Inhibitors of cyclic AMP phosphodiesterase. 3. Synthesis and biological evaluation of pyrido and imidazolyl analogues of 1,2,3,5-tetrahydro-2-oxoimidazo[2,1-b]quinazoline.
|
J Med Chem
|
1988
|
0.86
|
|
23
|
Flow cytometry of prostate cancer: relationship of DNA content to survival.
|
Cancer Res
|
1987
|
0.83
|
|
24
|
Prognostic significance of antigenic heterogeneity, Gleason grade, and ploidy of lymph node metastases in patients with prostate cancer.
|
Prostate
|
1992
|
0.83
|
|
25
|
Loss of chromosome 17 loci in prostate cancer detected by polymerase chain reaction quantitation of allelic markers.
|
Genes Chromosomes Cancer
|
1995
|
0.82
|
|
26
|
Inhibition of mouse natural killer cell activity by zinc.
|
J Natl Cancer Inst
|
1985
|
0.82
|
|
27
|
Aneusomy of chromosomes 7 and 17 detected by FISH in prostate cancer and the effects of selection in vitro.
|
Genes Chromosomes Cancer
|
1994
|
0.81
|
|
28
|
Dihydrochalcone sweeteners. Synthesis and sensory evaluation of sulfonate derivatives.
|
J Agric Food Chem
|
1977
|
0.81
|
|
29
|
Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase by nuclear variants of mycophenolic acid.
|
J Med Chem
|
1996
|
0.79
|
|
30
|
Serum chromogranin A: early detection of hormonal resistance in prostate cancer patients.
|
J Clin Lab Anal
|
1998
|
0.79
|
|
31
|
Staging of testis cancer. Combining serum markers, histologic parameters, and radiographic imaging.
|
Urol Clin North Am
|
1998
|
0.78
|
|
32
|
Heritability of the symptoms of benign prostatic hyperplasia and the roles of age and zonal prostate volumes in twins.
|
Urology
|
1999
|
0.78
|
|
33
|
Dihydrochalcone sweeteners. A study of the atypical temporal phenomena.
|
J Med Chem
|
1981
|
0.77
|
|
34
|
The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis.
|
J Urol
|
2000
|
0.77
|
|
35
|
Effects of age, sex steroids, and family relationships on volumes of prostate zones in men with and without prostate cancer.
|
Prostate
|
1995
|
0.76
|
|
36
|
Spangolite: an s = 1/2 maple leaf lattice antiferromagnet?
|
J Phys Condens Matter
|
2011
|
0.75
|
|
37
|
Effects of age and sex hormones on transition and peripheral zone volumes of prostate and benign prostatic hyperplasia in twins.
|
J Clin Endocrinol Metab
|
1997
|
0.75
|
|
38
|
Summary of transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer (by Paul F. Schellhammer, MD, and Willet F. Whitmore, Jr, MD). 1976.
|
Semin Urol Oncol
|
1997
|
0.75
|
|
39
|
Computerized microscopic analysis of prostatic fine needle aspirates. Comparison with breast aspirates.
|
Anal Quant Cytol Histol
|
1989
|
0.75
|
|
40
|
Diterpenoid sweeteners. Synthesis and sensory evaluation of stevioside analogues nondegradable to steviol.
|
J Med Chem
|
1981
|
0.75
|
|
41
|
Preservation of retroperitoneal lymph nodes in patients with locoregional nonseminomatous germ cell tumors: surveillance and primary chemotherapy.
|
Prog Clin Biol Res
|
1991
|
0.75
|
|
42
|
A common deletion at chromosomal region 17q21 in sporadic prostate tumors distal to BRCA1.
|
Genomics
|
2001
|
0.75
|
|
43
|
Flow cytometry in urologic oncology.
|
Urol Clin North Am
|
1986
|
0.75
|
|
44
|
Does transurethral resection of the prostate compromise the radical treatment of prostate cancer?
|
Semin Urol Oncol
|
1996
|
0.75
|
|
45
|
Angiomyolipoma of the kidney with lymph node involvement.
|
Ultrastruct Pathol
|
1992
|
0.75
|
|
46
|
Monitoring percent free PSA in serial specimens: improvement of test specificity, early detection, and identification of occult tumors.
|
J Clin Lab Anal
|
1998
|
0.75
|
|
47
|
Prostate specific antigen in patients with clinical stage C prostate cancer: relation to lymph node status and grade.
|
J Urol
|
1991
|
0.75
|